
@Article{ecn.2018.0415,
AUTHOR = {Jacek Karczewski, Ewelina Śledzi´ nska, Alina Baturo, Izabela Jończyk, Aleksander Maleszko, Paweł Samborski, Beata Begier-Krasińska, Agnieszka Dobrowolska},
TITLE = {Obesity and inﬂammation},
JOURNAL = {European Cytokine Network},
VOLUME = {29},
YEAR = {2018},
NUMBER = {3},
PAGES = {83--94},
URL = {http://www.techscience.com/ECN/v29n3/65403},
ISSN = {1952-4005},
ABSTRACT = {The prevalence of obesity has recently increased dramatically and has contributed to the increasing
prevalence of various pathological conditions, including type 2 diabetes mellitus, nonalcoholic fatty liver disease,
asthma, various types of cancer, cardiovascular and neurodegenerative diseases, and others. Accumulating evidence
points to localized inﬂammation in adipose tissue, which, in turn, promotes systemic low-grade inﬂammation as
a primary force contributing to the development of these pathologies. A better understanding of the underlying
mechanisms behind obesity-induced adipose tissue inﬂammation is required to develop effective therapeutic or
prophylactic strategies. This review is aimed to present the current knowledge of adipose tissue inﬂammation
associated with obesity.},
DOI = {10.1684/ecn.2018.0415}
}



